rs201001790
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 0P and 3B. BP4_ModerateBP6
The NM_006231.4(POLE):c.5542C>T(p.Leu1848Phe) variant causes a missense change. The variant allele was found at a frequency of 0.000062 in 1,613,976 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_006231.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
POLE | NM_006231.4 | c.5542C>T | p.Leu1848Phe | missense_variant | Exon 40 of 49 | ENST00000320574.10 | NP_006222.2 | |
POLE | XM_011534795.4 | c.5542C>T | p.Leu1848Phe | missense_variant | Exon 40 of 48 | XP_011533097.1 | ||
POLE | XM_011534797.4 | c.4621C>T | p.Leu1541Phe | missense_variant | Exon 32 of 40 | XP_011533099.1 | ||
POLE | XM_011534802.4 | c.2530C>T | p.Leu844Phe | missense_variant | Exon 16 of 24 | XP_011533104.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152184Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000155 AC: 39AN: 251098Hom.: 1 AF XY: 0.000140 AC XY: 19AN XY: 135670
GnomAD4 exome AF: 0.0000616 AC: 90AN: 1461792Hom.: 1 Cov.: 31 AF XY: 0.0000509 AC XY: 37AN XY: 727218
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152184Hom.: 0 Cov.: 32 AF XY: 0.000121 AC XY: 9AN XY: 74358
ClinVar
Submissions by phenotype
Hereditary cancer-predisposing syndrome Uncertain:1
The p.L1848F variant (also known as c.5542C>T), located in coding exon 40 of the POLE gene, results from a C to T substitution at nucleotide position 5542. The leucine at codon 1848 is replaced by phenylalanine, an amino acid with highly similar properties. This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Based on the available evidence, the clinical significance of this variant remains unclear. -
not provided Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at